Difference between revisions of "ENDO5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
Line 6: | Line 6: | ||
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest. | ||
+ | |||
__TOC__ | __TOC__ | ||
{| class="wikitable" style="margin:auto" | {| class="wikitable" style="margin:auto" | ||
Line 18: | Line 19: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
− | |CHAPTER 2 (PITUITARY TUMOURS) | + | | |
+ | ==== CHAPTER 2 (PITUITARY TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 280: | Line 282: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 3 (THYROID TUMOURS) | + | | |
+ | ==== CHAPTER 3 (THYROID TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 575: | Line 578: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 4 (PARATHYROID TUMOURS) | + | | |
+ | ==== CHAPTER 4 (PARATHYROID TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 650: | Line 654: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 5 (ADRENAL GLAND TUMOURS) | + | | |
+ | ==== CHAPTER 5 (ADRENAL GLAND TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 780: | Line 785: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 6 (ADRENAL MEDULLA AND EXTRA-ADRENAL PARAGANGLIA TUMOURS) | + | | |
+ | ==== CHAPTER 6 (ADRENAL MEDULLA AND EXTRA-ADRENAL PARAGANGLIA TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 888: | Line 894: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 7 (PANCREATIC NEUROENDOCRINE NEOPLASMS) | + | | |
+ | ==== CHAPTER 7 (PANCREATIC NEUROENDOCRINE NEOPLASMS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,029: | Line 1,036: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 8 (NEUROENDOCRINE NEOPLASMS IN NON-ENDOCRINE ORGANS) | + | | |
+ | ==== CHAPTER 8 (NEUROENDOCRINE NEOPLASMS IN NON-ENDOCRINE ORGANS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,126: | Line 1,134: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 9 (MESENCHYMAL AND STROMAL TUMOURS) | + | | |
+ | ==== CHAPTER 9 (MESENCHYMAL AND STROMAL TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,289: | Line 1,298: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 10 (HAEMATOLYMPHOID TUMOURS) | + | | |
+ | ==== CHAPTER 10 (HAEMATOLYMPHOID TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,386: | Line 1,396: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 11 (GERM CELL TUMOURS) | + | | |
+ | ==== CHAPTER 11 (GERM CELL TUMOURS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,428: | Line 1,439: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 12 (METASTASIS) | + | | |
+ | ==== CHAPTER 12 (METASTASIS) ==== | ||
| | | | ||
---- | ---- | ||
Line 1,481: | Line 1,493: | ||
| | | | ||
|- | |- | ||
− | |CHAPTER 13 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH ENDOCRINE LESIONS AND TUMOURS) | + | | |
+ | ==== CHAPTER 13 (GENETIC TUMOUR SYNDROMES ASSOCIATED WITH ENDOCRINE LESIONS AND TUMOURS) ==== | ||
| | | | ||
---- | ---- |
Latest revision as of 14:08, 10 September 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.